DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Adler S, Reichenbach S, Gloor A. et al.
Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis.
Rheumatology (Oxford).
2019.
DOI: 10.1093/rheumatology/kez091
Access:
We do not assume any responsibility for the contents of the web pages of other providers.